Article
ADAP regulates cell cycle progression of T cells via control of cyclin E and Cdk2 expression through two distinct CARMA1-dependent signaling pathways.
Department of Laboratory Medicine and Pathology, Center for Immunology, Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Molecular and cellular biology (impact factor:
6.06).
03/2012;
32(10):1908-17.
DOI:10.1128/MCB.06541-11
pp.1908-17
Source: PubMed
- Citations (1)
-
Cited In (0)
-
Article: The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway.
[show abstract] [hide abstract]
ABSTRACT: Members of the c-Jun NH(2)-terminal kinase (JNK) family play crucial roles in cell activation, differentiation, and apoptosis. Although many studies have indicated that JNK1 and JNK2 have functional differences and redundancy, the upstream signaling pathway that selectively activates JNK1 or JNK2 remains unknown. In this study, we have revealed a selective mechanism of JNK activation, in which JNK2, but not JNK1, was regulated by CARMA1, a scaffold molecule, after stimulation of the T cell receptor (TCR). This CARMA1-dependent regulation of JNK2 worked through the scaffold molecule Bcl10, which was inducibly associated with JNK2 and served as a JNK-interacting protein (JIP)-like scaffold to assemble the kinases JNK2, MKK7, and TAK1. Finally, we showed that CARMA1- and Bcl10-mediated JNK2 activation had a critical role in regulating the amount of c-Jun protein. Together, our studies provide genetic evidence that JNK1 and JNK2 are differentially regulated in the TCR-signaling pathway and play different functions.Immunity 02/2007; 26(1):55-66. · 21.64 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
ADAP-deficient T cells
ADAP-deficient T cells exhibit
ADAP-dependent JNK activation
CARMA1 adapter
cell cycle progression
cyclin-dependent kinase 2
degranulation-promoting adapter protein
distinct CARMA1-dependent control
JNK)-mediated Cdk2 induction
key cell cycle proteins
mitogen-activated protein
multifunctional scaffold
NF-κB pathway
protein kinase C θ
regulates T cell receptor-mediated activation
serine/threonine kinase
subsequent c-Jun kinase
T cell activation
T cell receptor stimulation
T cell receptor-mediated proliferation